Patent · US Active

Intestinal bacteria butyribacterintestini and application thereof

US11033614B2 · kind B2 · utility

1Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 21, 2016
Grant dateJun 15, 2021
Priority date
Expiry dateOct 4, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N1/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.